To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
At Karmanos, we believe in care beyond medicine and stand united with the community in the fight against cancer. Our monthly newsletter, ‘Caring. Healing. Informing.’ is an essential part of this commitment. Patients, families, caregivers, friends, and community members in the 46 counties we serve are connected by this newsletter – a beacon of hope and knowledge. From new, industry-leading cancer treatments to inspiring stories of resilience from our patients, including groundbreaking updates in research and care and information about special events, you’ll feel part of Team Karmanos. Stand with us and sign up to receive ‘Caring. Healing. Informing.’ and be part of our story.
WDIV Local 4’s Rhonda Walker challenged women who were overdue for their mammogram to make their appointment. She participated in her own challeng...
With less than 60 days in her new job, Lisa Whitmore Davis found herself in the emergency room. It was a medical mystery. At the time, she was a 5...
The Barbara Ann Karmanos Cancer Institute and Wayne State University present the annual Head and Neck Cancer Symposium on Saturday, Nov. 8, 2025, ...